Jun 132016
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA – CytomX Therapeutics (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody therapeutics for the treatment of cancer, today announced that John “Chip” A.… => Read more

CytomX Therapeutics appoints Dr Chip Scarlett to the Board of Directors

From:: CytomX Therapeutics appoints Dr Chip Scarlett to the Board of Directors

 Posted by at 1:00 pm

Sorry, the comment form is closed at this time.

%d bloggers like this: